|
|
|
| |
|
|
| |
The latest antibodies news from News Medical |
|
|
|
 | | |
Develop Better Tissue Analysis Strategies with Multiplexing
As tissue analysis grows more complex, traditional IHC workflows can limit the depth of biological insight. This practical eBook explores how multiplexing enables simultaneous biomarker analysis, improved spatial context, and streamlined workflows.
Discover panel design strategies, validation best practices, and real-world applications for advancing tissue-based research.
| |
|
|
|
|
 | | | An international research group recently demonstrated that the antibody NG101 promotes the regeneration of damaged spinal cord tissue. | | | | | Persistent symptoms after COVID-19 infection continue to affect millions of people worldwide, even as the number of acute infections has declined. | | | | | Monoclonal antibodies can block a key immune‑related protein that drives the spread of brain cell damage in Parkinson's disease (PD). | | | | | For years, researchers have been hoping for vaccines that protect people against not just one strain of HIV, but every strain of the quickly mutating virus. | | | | | Scientists have revealed the process by which cells can internally digest bacteria and viruses. | | | | | The immune system is our frontline protection against infection, continually searching for and destroying unknown pathogens. | | | | | In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (Leqembi, from Biogen) and donanemab (KisunlaTM, from Eli Lilly and Company), both based on immunotherapy (the use of molecules from the immune system to treat diseases). | |
|
|
|
 | | | How would you rate today's newsletter?
| |
|
|
|
 | | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|